ArticleOrthopedic reviews2026
Complement Proteins C1q-C5 as Context‑Dependent Regulators of Osteoblast Function and Fracture Healing: A Systematic Review.
Article in Orthopedic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Complement proteins (C1q-C5) participate in immune surveillance and inflammation, but their roles in osteoblast biology and fracture healing remain generally undefined. Emerging evidence suggests that complement activation may exert both pro‑regenerative and pro‑inflammatory effects, depending on receptor engagement and physiological context. Methods: A systematic review was conducted following PRISMA guidelines, using a semantic search strategy to identify studies evaluating complement components C1q-C5 in osteoblast function or fracture‑healing outcomes. 20 studies met the inclusion criteria, including rodent fracture models, in vitro osteoblast and osteoclast assays, aging and estrogen‑deficiency models, and receptor‑specific genetic manipulations. Results: Across studies, C3a/C3aR signaling consistently promoted osteoblast differentiation, migration, and early callus organization, while C3 deficiency or C3aR inhibition preserved bone formation in aging and estrogen‑deficiency states. In contrast, C5a/C5aR1 activation induced pro‑inflammatory osteoblast phenotypes, increased osteoclastogenic cytokines, and impaired matrix organization, particularly when complement activity was excessive. C5aR1 blockade had little to no effect in uncomplicated fractures, but restored healing in trauma‑induced systemic inflammation. Receptor‑specific models demonstrated that C5aR1 drives early inflammatory signaling, whereas C5aR2 modulates its resolution. Conclusions: Complement proteins act as contextual regulators of skeletal repair, supporting osteoblast-mediated regeneration under physiologic activation, while impairing healing when over-activated. These findings highlight the therapeutic potential of targeted complement modulation in inflammatory fracture environments and underscore the need for human studies to define translational applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.